2-chloro-n(6)cyclopentyladenosine has been researched along with erythrosine in 1 studies
Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (erythrosine) | Trials (erythrosine) | Recent Studies (post-2010) (erythrosine) |
---|---|---|---|---|---|
252 | 0 | 43 | 15,483 | 108 | 2,574 |
Protein | Taxonomy | 2-chloro-n(6)cyclopentyladenosine (IC50) | erythrosine (IC50) |
---|---|---|---|
Genome polyprotein | Zika virus | 1.7 | |
large T antigen | Betapolyomavirus macacae | 13.04 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lasley, RD; Mentzer, RM; Narayan, P | 1 |
1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and erythrosine
Article | Year |
---|---|
Adenosine A1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes.
Topics: Adenosine; Aniline Compounds; Animals; Calcium; Decanoic Acids; Drug Synergism; Fluoresceins; Fluorescent Dyes; Glyburide; Heart Ventricles; Hydroxy Acids; Ion Transport; Male; Microscopy, Fluorescence; Myocardial Contraction; Myocardial Reperfusion; Myocardial Stunning; Myocardium; Oxidation-Reduction; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Purinergic P1; Xanthenes; Xanthines | 2001 |